The Ensign Group, Inc.
ENSGNasdaqCIK 1125376Healthcare / Healthcare Providers & Servicesfiscal year ends December66 quarters since 2010
Latest quarter Q3 FY2026, filed October 27, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.
Share price
Daily candlesticks from November 11, 2024 to November 6, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.
The last 16 quarters
Q4 FY2022 to Q3 FY2026, through the filing of October 27, 2026.
Net income losses drawn in red.
Positions at each quarter end, as filed; short-term investments are not included.
Income statement
Last eight quarters, newest first, through Q3 FY2026 filed October 27, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Oct 27, 2026 | Q2 FY2026ended Jun 30, 2026filed Jul 27, 2026 | Q1 FY2026ended Mar 31, 2026filed Apr 30, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 4, 2026 | Q3 FY2025ended Sep 30, 2025filed Nov 3, 2025 | Q2 FY2025ended Jun 30, 2025filed Jul 24, 2025 | Q1 FY2025ended Mar 31, 2025filed Apr 29, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 5, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,477 | 1,432 | 1,382 | 1,354 | 1,290 | 1,221 | 1,167 | 1,126 | +14.5% |
| Cost of revenue | 1,167 | 1,134 | 1,096 | 1,075 | 1,045 | 972 | 928 | 897 | +11.7% |
| Gross profit | — | — | — | — | — | — | — | — | — |
| Research and development | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | 80 | 86 | 74 | 71 | 67 | 69 | 63 | 56 | +18.2% |
| Operating income | 138 | 123 | 125 | 124 | 96 | 104 | 101 | 101 | +43.4% |
| Other income (expense) | 2 | 11 | 4 | 6 | 10 | 8 | 5 | 5 | −78.7% |
| Pretax income | 140 | 134 | 129 | 130 | 107 | 112 | 107 | 106 | +31.5% |
| Income tax | 36 | 34 | 29 | 35 | 23 | 28 | 26 | 26 | +57.8% |
| Net income | 104 | 100 | 100 | 95 | 84 | 84 | 80 | 80 | +24.4% |
| Diluted EPS ($) | 1.76 | 1.68 | 1.67 | — | 1.42 | 1.44 | 1.37 | — | +23.9% |
| Diluted shares (millions) | 59 | 59 | 60 | — | 59 | 59 | 59 | — | — |
Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.
Balance sheet
Last eight quarters, newest first, through Q3 FY2026 filed October 27, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Oct 27, 2026 | Q2 FY2026ended Jun 30, 2026filed Jul 27, 2026 | Q1 FY2026ended Mar 31, 2026filed Apr 30, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 4, 2026 | Q3 FY2025ended Sep 30, 2025filed Nov 3, 2025 | Q2 FY2025ended Jun 30, 2025filed Jul 24, 2025 | Q1 FY2025ended Mar 31, 2025filed Apr 29, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 5, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 338 | 262 | 539 | 504 | 444 | 364 | 283 | 465 | −23.9% |
| Short-term investments | 54 | 59 | 56 | 69 | 63 | 54 | 62 | 62 | −13.6% |
| Total current assets | 1,155 | 1,071 | 1,320 | 1,272 | 1,207 | 1,067 | 986 | 1,158 | −4.3% |
| Total assets | 5,998 | 5,749 | 5,612 | 5,463 | 5,226 | 4,930 | 4,760 | 4,669 | +14.8% |
| Total current liabilities | 963 | 885 | 848 | 894 | 825 | 756 | 705 | 743 | +16.7% |
| Long-term debt | 195 | 136 | 136 | 138 | 139 | 140 | 141 | 142 | +40.5% |
| Total liabilities | 3,435 | 3,304 | 3,242 | 3,228 | 3,104 | 2,909 | 2,830 | 2,829 | +10.7% |
| Stockholders’ equity | 2,559 | 2,442 | 2,366 | 2,232 | 2,119 | 2,018 | 1,927 | 1,837 | +20.8% |
| Shares outstanding (millions) | 58 | 58 | 58 | 58 | 58 | 58 | 57 | 57 | — |
Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.
Cash flow statement
Last eight quarters, newest first, through Q3 FY2026 filed October 27, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Oct 27, 2026 | Q2 FY2026ended Jun 30, 2026filed Jul 27, 2026 | Q1 FY2026ended Mar 31, 2026filed Apr 30, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 4, 2026 | Q3 FY2025ended Sep 30, 2025filed Nov 3, 2025 | Q2 FY2025ended Jun 30, 2025filed Jul 24, 2025 | Q1 FY2025ended Mar 31, 2025filed Apr 29, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 5, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 240 | 172 | 100 | 183 | 153 | 156 | 72 | 100 | +57.0% |
| Capital expenditures | — | — | — | — | — | — | — | — | — |
| Free cash flow (CFO − capex) | — | — | — | — | — | — | — | — | — |
| Depreciation and amortization | 33 | 31 | 29 | 28 | 27 | 26 | 24 | 23 | +22.6% |
| Share repurchases | 7 | 40 | 0 | 0 | 0 | 9 | 11 | 0 | — |
| Dividends paid | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | +5.1% |
10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.
Annual statements
Every fiscal year filed, newest first, through FY2025 filed February 4, 2026.
Income statement
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 4, 2026 | FY2024ended Dec 31, 2024filed Feb 5, 2025 | FY2023ended Dec 31, 2023filed Feb 1, 2024 | FY2022ended Dec 31, 2022filed Feb 2, 2023 | FY2021ended Dec 31, 2021filed Feb 9, 2022 | FY2020ended Dec 31, 2020filed Feb 3, 2021 | FY2019ended Dec 31, 2019filed Feb 5, 2020 | FY2018ended Dec 31, 2018filed Feb 6, 2019 | FY2017ended Dec 31, 2017filed Feb 8, 2018 | FY2016ended Dec 31, 2016filed Feb 8, 2017 | FY2015ended Dec 31, 2015filed Feb 10, 2016 | FY2014ended Dec 31, 2014filed Feb 9, 2015 | FY2013ended Dec 31, 2013filed Feb 13, 2014 | FY2012ended Dec 31, 2012filed Feb 13, 2013 | FY2011ended Dec 31, 2011filed Feb 16, 2012 | FY2010ended Dec 31, 2010filed Aug 3, 2011 | FY2009ended Dec 31, 2009filed Aug 3, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5,032 | 4,238 | 3,708 | 3,025 | 2,627 | 2,387 | 2,037 | 1,755 | 1,598 | 1,655 | 1,342 | 1,027 | 905 | 823 | 758 | 650 | 542 |
| Cost of revenue | 4,019 | 3,377 | 2,941 | 2,354 | 2,020 | 1,865 | 1,621 | 1,418 | 1,313 | 1,342 | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Research and development | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | 270 | 225 | 263 | 159 | 152 | 130 | 111 | 91 | 74 | 69 | 64 | 57 | 40 | 32 | 30 | 26 | 21 |
| Operating income | 425 | 358 | 255 | 297 | 260 | 223 | 129 | 85 | 43 | 92 | 93 | 73 | 58 | 78 | 91 | 76 | 59 |
| Other income (expense) | 30 | 28 | 17 | (8) | (2) | (6) | (13) | (13) | (12) | (6) | (2) | (12) | (12) | (12) | (14) | (9) | (5) |
| Pretax income | 456 | 386 | 273 | 289 | 258 | 218 | 116 | 72 | 31 | 86 | 91 | 61 | 46 | 66 | 77 | 67 | 54 |
| Income tax | 111 | 88 | 63 | 64 | 60 | 46 | 24 | 13 | 14 | 33 | 35 | 27 | 20 | 25 | 29 | 26 | 21 |
| Net income | 344 | 298 | 209 | 225 | 195 | 170 | 111 | 92 | 40 | 50 | 55 | 36 | 24 | 41 | 48 | 41 | 32 |
| Diluted EPS ($) | 5.84 | 5.12 | 3.65 | 3.95 | 3.42 | 3.06 | 1.97 | 1.70 | 0.77 | 0.96 | 1.06 | 0.78 | 0.54 | 0.93* | 1.10* | 0.96* | 0.78* |
| Diluted shares (millions) | 59 | 58 | 57 | 57 | 57 | 56 | 56 | 54 | 53 | 52 | 52 | 46 | 45 | 44* | 43* | 42* | 42* |
Balance sheet
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 4, 2026 | FY2024ended Dec 31, 2024filed Feb 5, 2025 | FY2023ended Dec 31, 2023filed Feb 1, 2024 | FY2022ended Dec 31, 2022filed Feb 2, 2023 | FY2021ended Dec 31, 2021filed Feb 9, 2022 | FY2020ended Dec 31, 2020filed Feb 3, 2021 | FY2019ended Dec 31, 2019filed Feb 5, 2020 | FY2018ended Dec 31, 2018filed Feb 6, 2019 | FY2017ended Dec 31, 2017filed Feb 8, 2018 | FY2016ended Dec 31, 2016filed Feb 8, 2017 | FY2015ended Dec 31, 2015filed Feb 10, 2016 | FY2014ended Dec 31, 2014filed Feb 9, 2015 | FY2013ended Dec 31, 2013filed Feb 13, 2014 | FY2012ended Dec 31, 2012filed Feb 13, 2013 | FY2011ended Dec 31, 2011filed Feb 16, 2012 | FY2010ended Dec 31, 2010filed Aug 3, 2011 | FY2009ended Dec 31, 2009filed Aug 3, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 504 | 465 | 510 | 316 | 262 | 237 | 59 | 31 | 42 | 58 | 42 | 50 | 66 | 41 | 30 | 72 | 39 |
| Short-term investments | 69 | 62 | 17 | 15 | 14 | 13 | 18 | 9 | 13 | 12 | 2 | 6 | 6 | 5 | 0 | — | — |
| Total current assets | 1,272 | 1,158 | 1,047 | 781 | 640 | 583 | 411 | 348 | 368 | 334 | 280 | 214 | 211 | 168 | 141 | 160 | — |
| Total assets | 5,463 | 4,669 | 4,178 | 3,452 | 2,851 | 2,546 | 2,362 | 2,198 | 1,102 | 1,001 | 748 | 494 | 760 | 691 | 596 | 480 | — |
| Total current liabilities | 894 | 743 | 735 | 582 | 523 | 562 | 343 | 269 | 226 | 212 | 180 | 130 | 112 | 121 | 100 | 83 | — |
| Long-term debt | 138 | 142 | 145 | 149 | 153 | 118 | 330 | 233 | 303 | 275 | 99 | 68 | 252 | 201 | 182 | 139 | — |
| Total liabilities | 3,228 | 2,829 | 2,680 | 2,203 | 1,829 | 1,727 | 1,706 | 1,587 | 602 | 541 | 321 | 236 | 403 | 363 | 319 | — | — |
| Stockholders’ equity | 2,232 | 1,837 | 1,492 | 1,247 | 1,021 | 818 | 654 | 591 | 492 | 456 | 427 | 259 | 356 | 326 | 277 | 228 | 188 |
| Shares outstanding (millions) | 58 | 57 | 57 | 56 | 55 | 55 | 54 | 53 | 51 | 51 | 51 | 45* | 44* | 44* | 42* | — | — |
Cash flow statement
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 4, 2026 | FY2024ended Dec 31, 2024filed Feb 5, 2025 | FY2023ended Dec 31, 2023filed Feb 1, 2024 | FY2022ended Dec 31, 2022filed Feb 2, 2023 | FY2021ended Dec 31, 2021filed Feb 9, 2022 | FY2020ended Dec 31, 2020filed Feb 3, 2021 | FY2019ended Dec 31, 2019filed Feb 5, 2020 | FY2018ended Dec 31, 2018filed Feb 6, 2019 | FY2017ended Dec 31, 2017filed Feb 8, 2018 | FY2016ended Dec 31, 2016filed Feb 8, 2017 | FY2015ended Dec 31, 2015filed Feb 10, 2016 | FY2014ended Dec 31, 2014filed Feb 9, 2015 | FY2013ended Dec 31, 2013filed Feb 13, 2014 | FY2012ended Dec 31, 2012filed Feb 13, 2013 | FY2011ended Dec 31, 2011filed Feb 16, 2012 | FY2010ended Dec 31, 2010filed Aug 3, 2011 | FY2009ended Dec 31, 2009filed Aug 3, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 564 | 347 | 377 | 273 | 276 | 373 | 192 | 210 | 80 | 74 | 33 | 85 | 37 | 82 | 73 | 61 | 46 |
| Capital expenditures | — | — | — | — | — | — | 72 | 51 | 54 | 66 | 60 | 54 | 30 | 39 | 41 | 29 | 22 |
| Free cash flow (CFO − capex) | — | — | — | — | — | — | 121 | 159 | 25 | 8 | (27) | 31 | 8 | 43 | 32 | 32 | 24 |
| Depreciation and amortization | 104 | 84 | 72 | 62 | 56 | 55 | 51 | 45 | 42 | 39 | 28 | 26 | 34 | 28 | 23 | 17 | 13 |
| Share repurchases | 20 | 0 | 0 | 30 | 10 | 25 | 6 | 0 | 7 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Dividends paid | 14 | 14 | 13 | 12 | 12 | 11 | 10 | 9 | 9 | 8 | 7 | 6 | 4 | 7 | 5 | 4 | 4 |
Insider activity
Form 4 filings by officers, directors and 10% owners, November 9, 2024 to November 9, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.
The last 25 transactions
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | Uychiat Pison Marivic | Director | tax withholding | 163 | $182.39 | $30K | 15,115 | Nov 6, 2026 |
| Nov 4, 2026 | Uychiat Pison Marivic | Director | award | 1,600 | $0.00 | — | 15,278 | Nov 6, 2026 |
| Oct 16, 2026 | Parkinson Mark Vincent | Director | open-market sale10b5-1 | 100 | $179.62 | $18K | 4,400 | Oct 19, 2026 |
| Oct 15, 2026 | Parkinson Mark Vincent | Director | award | 600 | $0.00 | — | 4,500 | Oct 19, 2026 |
| Oct 15, 2026 | Agwunobi John O | Director | award | 600 | $0.00 | — | 10,103 | Oct 19, 2026 |
| Oct 15, 2026 | Abbott Swati Bargotra | Director | award | 600 | $0.00 | — | 21,432 | Oct 19, 2026 |
| Oct 15, 2026 | Blouin Ann Scott | Director | award | 600 | $0.00 | — | 24,277 | Oct 19, 2026 |
| Oct 15, 2026 | Shaw Daren | Director | award | 600 | $0.00 | — | 25,526 | Oct 19, 2026 |
| Oct 15, 2026 | Smith Barry M | Director | award | 600 | $0.00 | — | 22,552 | Oct 19, 2026 |
| Sep 10, 2026 | Uychiat Pison Marivic | Director | gift | 580 | $0.00 | — | 13,678 | Sep 14, 2026 |
| Aug 11, 2026 | Burton Spencer | President and COO | gift | 2,500 | $0.00 | — | 65,970 | Aug 13, 2026 |
| Jul 27, 2026 | Blouin Ann Scott | Director | open-market sale10b5-1 | 175 | $181.88 | $32K | 23,877 | Jul 29, 2026 |
| Jul 27, 2026 | Blouin Ann Scott | Director | open-market sale10b5-1 | 200 | $185.00 | $37K | 23,677 | Jul 29, 2026 |
| Jul 20, 2026 | Agwunobi John O | Director | open-market sale10b5-1 | 392 | $171.06 | $67K | 9,503 | Jul 22, 2026 |
| Jul 16, 2026 | Parkinson Mark Vincent | Director | open-market sale10b5-1 | 100 | $168.12 | $17K | 3,900 | Jul 17, 2026 |
| Jul 15, 2026 | Smith Barry M | Director | award | 600 | $0.00 | — | 21,952 | Jul 17, 2026 |
| Jul 15, 2026 | Shaw Daren | Director | award | 600 | $0.00 | — | 24,926 | Jul 17, 2026 |
| Jul 15, 2026 | Blouin Ann Scott | Director | award | 600 | $0.00 | — | 24,052 | Jul 17, 2026 |
| Jul 15, 2026 | Abbott Swati Bargotra | Director | award | 600 | $0.00 | — | 20,832 | Jul 17, 2026 |
| Jul 15, 2026 | Agwunobi John O | Director | award | 600 | $0.00 | — | 9,895 | Jul 17, 2026 |
| Jul 15, 2026 | Parkinson Mark Vincent | Director | award | 600 | $0.00 | — | 4,000 | Jul 17, 2026 |
| Jun 2, 2026 | Smith Barry M | Director | open-market sale10b5-1 | 700 | $164.28 | $115K | 21,352 | Jun 4, 2026 |
| May 27, 2026 | Burton Spencer | President and COO | tax withholding | 264 | $171.97 | $45K | 68,470 | May 28, 2026 |
| May 27, 2026 | Keetch Chad | CIO and EVP | tax withholding | 306 | $171.97 | $53K | 109,735 | May 28, 2026 |
| May 27, 2026 | Port Barry | Chief Executive Officer, Director | tax withholding | 509 | $171.97 | $88K | 80,784 | May 28, 2026 |
Full insider history for The Ensign Group, Inc., or insider activity across all companies. A record of filings, not a recommendation.
Sources
Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.
- Filer
- ENSIGN GROUP, INC, CIK 1125376 on EDGAR
- Extract generated
- November 8, 2026
- Withheld
- none
- Repaired
- none
XBRL concepts behind each line
Income statement
RevenueFromContractWithCustomerExcludingAssessedTax, SalesRevenueServicesNetCostOfGoodsAndServicesSoldGeneralAndAdministrativeExpenseOperatingIncomeLossNonoperatingIncomeExpense, OtherNonoperatingIncomeExpenseIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncomeTaxExpenseBenefitNetIncomeLossEarningsPerShareDilutedWeightedAverageNumberOfDilutedSharesOutstandingBalance sheet
CashAndCashEquivalentsAtCarryingValueShortTermInvestmentsAssetsCurrentAssetsLiabilitiesCurrentLongTermDebt, LongTermDebtNoncurrentLiabilitiesStockholdersEquitydei:EntityCommonStockSharesOutstandingCash flow statement
NetCashProvidedByUsedInOperatingActivitiesPaymentsToAcquirePropertyPlantAndEquipmentDepreciationDepletionAndAmortizationPaymentsForRepurchaseOfCommonStockPaymentsOfDividendsThe data
The statements on this page as files, generated November 8, 2026.
- JSON file
/data/financials/ENSG.json